Study Examines Trends in Esophageal Cancer Disparities Over Time

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 31, 2024 -- From 1999 to 2020, age-adjusted esophageal cancer mortality decreased among Black adults but stabilized among White adults, reducing the racial mortality gap, according to a study published online July 24 in the Journal of Gastroenterology and Hepatology.

Chun-Wei Pan, M.D., from the John H. Stroger, Jr., Hospital of Cook County in Chicago, and colleagues described updated esophageal cancer mortality trends among Black and White adults from 1999 to 2020 using data from CDC-WONDER.

The researchers identified 303,267 esophageal cancer deaths from 1999 to 2020 in the United States, with significant racial disparities. The age-adjusted mortality rate decreased from 6.52 to 2.62 per 100,000 among Black adults and from 4.19 to 3.97 among White adults, narrowing the racial mortality gap. A decrease was seen in the mortality rate among Black women, from 3.31 to 2.29 per 100,000, while White women had an increase from 1.52 to 1.99. Similar trends were seen in young men, with a decrease in the rate from 12.82 to 6.26 per 100,000 among Black men, and an increase from 9.90 to 10.57 per 100,000 White men. In the Midwest and South, Black adults initially had higher mortality rates than Whites, but over time, this gap reduced. Across all regions, mortality rates were lower for Black men by 2020.

"To address these disparities, we propose targeted screening programs based on the predominant histological subtypes in each racial group, increased access to endoscopic treatment, and investing in research on novel screening tools, and public health interventions aimed at risk factors like obesity," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords